Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine vs Placebo for Third Molar Surgery Pain
NCT01541059Phase 4Completed
- Sponsor
- CHU Nîmes
- Start
- Jun 2012
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Placebo with Ropivacaine (2 arms). Primary endpoint: 24 hour area under the curve for pain. Started Jun 2012; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01541059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541059.